Analystreport

Arcus Biosciences, Inc. (NYSE: RCUS) had its price target lowered by analysts at Citigroup Inc. from $48.00 to $40.00.

Arcus Biosciences, Inc.  (RCUS) 
Last arcus biosciences, inc. earnings: 3/5 04:10 pm Check Earnings Report